Patents by Inventor Thomas Lindel

Thomas Lindel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis of morin and morin derivatives
    Patent number: 11312696
    Abstract: The invention relates to a method for directly producing morin derivatives and high-purity morin of formula (I). The invention also relates to morin derivatives and high-purity morin that can be obtained using the claimed method.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: April 26, 2022
    Assignee: ORSATEC GMBH
    Inventors: Thomas Lindel, Steffen Mende
  • SYNTHESIS OF MORIN AND MORIN DERIVATIVES
    Publication number: 20200308131
    Abstract: The invention relates to a method for directly producing morin derivatives and high-purity morin of formula (I). The invention also relates to morin derivatives and high-purity morin that can be obtained using the claimed method.
    Type: Application
    Filed: November 21, 2018
    Publication date: October 1, 2020
    Inventors: Thomas LINDEL, Steffen MENDE
  • Eleutherobin and analogs thereof
    Patent number: 5473057
    Abstract: Eleutherobin is a glycosylated diterpene which has the structural formula: ##STR1## Eleutherobin is a cytotoxic agent which is toxic to carcinoma cancer cells. Analogs of eleutherobin are also disclosed.
    Type: Grant
    Filed: November 9, 1994
    Date of Patent: December 5, 1995
    Assignee: The Regents of the University of California
    Inventors: William H. Fenical, Paul R. Jensen, Thomas Lindel